ZA95936B - Formulations for orally admimistered phamaceutical agents - Google Patents

Formulations for orally admimistered phamaceutical agents

Info

Publication number
ZA95936B
ZA95936B ZA95936A ZA95936A ZA95936B ZA 95936 B ZA95936 B ZA 95936B ZA 95936 A ZA95936 A ZA 95936A ZA 95936 A ZA95936 A ZA 95936A ZA 95936 B ZA95936 B ZA 95936B
Authority
ZA
South Africa
Prior art keywords
admimistered
phamaceutical
orally
formulations
agents
Prior art date
Application number
ZA95936A
Other languages
English (en)
Inventor
Stephanie A Sweetana
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA95936B publication Critical patent/ZA95936B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA95936A 1994-03-01 1995-02-06 Formulations for orally admimistered phamaceutical agents ZA95936B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20342494A 1994-03-01 1994-03-01

Publications (1)

Publication Number Publication Date
ZA95936B true ZA95936B (en) 1995-10-09

Family

ID=22753951

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95936A ZA95936B (en) 1994-03-01 1995-02-06 Formulations for orally admimistered phamaceutical agents

Country Status (15)

Country Link
EP (1) EP0670166A3 (de)
JP (1) JPH0840936A (de)
KR (1) KR950031039A (de)
CN (1) CN1114588A (de)
AU (1) AU1354495A (de)
BR (1) BR9500754A (de)
CA (1) CA2138607A1 (de)
CZ (1) CZ51995A3 (de)
HU (1) HUT75252A (de)
IL (1) IL112745A0 (de)
NO (1) NO950134L (de)
NZ (1) NZ270145A (de)
PE (1) PE10396A1 (de)
PL (1) PL307469A1 (de)
ZA (1) ZA95936B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
JP2002534371A (ja) * 1999-01-06 2002-10-15 コリア リサーチ インスティテュート オブ ケミカル テクノロジー 水不溶性薬物を含む医薬的活性成分の製造方法及びそれを含む経口投与用医薬組成物
KR100435141B1 (ko) * 2000-12-28 2004-06-09 한미약품 주식회사 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
KR100455216B1 (ko) * 2001-06-27 2004-11-09 한미약품 주식회사 난용성 항진균제의 경구투여용 조성물 및 이의 제조 방법
KR100425755B1 (ko) * 2001-08-27 2004-04-03 주식회사 원진신약 이트라코나졸을 함유하는 조성물 및 그 제조방법
US20050058670A1 (en) * 2003-09-09 2005-03-17 Jong-Soo Woo Oral itraconazole composition which is not affected by ingested food and process for preparing same
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
WO2010059727A1 (en) * 2008-11-20 2010-05-27 Teikoku Pharma Usa, Inc. Pyrazalone derivative formulations
US20110070293A1 (en) 2009-09-23 2011-03-24 Javeri Indu Methods for the Preparation of Liposomes Comprising Docetaxel
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
WO2018102345A1 (en) * 2016-11-30 2018-06-07 Agrobiologics Llc Use of the antifungal aureobasidin a in agriculture
WO2020236802A1 (en) * 2019-05-20 2020-11-26 Poviva Corp. Compositions comprising biologically active agents and bile salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JPH04305534A (ja) * 1991-04-02 1992-10-28 Takara Shuzo Co Ltd オーレオバシジン類製剤
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
JPH0672890A (ja) * 1992-06-26 1994-03-15 Nippon Kayaku Co Ltd オーレオバシジン類の乳化製剤

Also Published As

Publication number Publication date
HU9500618D0 (en) 1995-04-28
KR950031039A (ko) 1995-12-18
BR9500754A (pt) 1995-10-24
EP0670166A2 (de) 1995-09-06
PL307469A1 (en) 1995-09-04
PE10396A1 (es) 1996-04-11
NO950134D0 (no) 1995-01-13
CN1114588A (zh) 1996-01-10
AU1354495A (en) 1995-09-07
HUT75252A (en) 1997-05-28
JPH0840936A (ja) 1996-02-13
NO950134L (no) 1995-09-04
NZ270145A (en) 1996-08-27
CZ51995A3 (en) 1995-10-18
CA2138607A1 (en) 1995-09-02
EP0670166A3 (de) 1996-06-12
IL112745A0 (en) 1995-05-26

Similar Documents

Publication Publication Date Title
AP9500733A0 (en) Pharmaceutical formulations
GB9404248D0 (en) Pharmaceutical formulations
ZA9510427B (en) Pharmaceutical orally applicable composition
ZA9510428B (en) Pharmaceutical orally applicable composition
ZA95936B (en) Formulations for orally admimistered phamaceutical agents
GB9413542D0 (en) Pharmaceutical formulations
GB9410210D0 (en) Pharmaceutically useful compounds
GB9413803D0 (en) Pharmaceutically useful compounds
GB9414065D0 (en) Pharmaceutically useful compounds
GB9416397D0 (en) Pharmaceutically useful compounds
GB9412214D0 (en) Pharmaceutically useful compounds
GB9410215D0 (en) Pharmaceutically useful compounds
GB9416685D0 (en) Semiconductor photolithography
GB9406999D0 (en) Pharmaceutically active compounds
GB9411878D0 (en) Pharmaceutically active compounds
GB9400160D0 (en) Pharmaceutically active compounds
GB9403692D0 (en) Pharmaceutically active compounds
GB9407826D0 (en) Pharmaceutically active compounds
GB9405197D0 (en) Pharmaceutically active compounds
GB9405653D0 (en) Pharmaceutically active compounds
GB9406729D0 (en) Pharmaceutically active compounds
GB9406801D0 (en) Pharmaceutically active compounds
GB9400920D0 (en) Pharmaceutically active compounds
GB9407000D0 (en) Pharmaceutically active compounds
GB9407017D0 (en) Pharmaceutically active compounds